CMND Stock Catalyst: Clearmind Medicine Granted New U.S. Patent

Jun 29, 2026 · 7:55am ET

Enhances global patent strength

Max move

+50.0%

High of day $3.60

Sparker timei

7:55am ET

CMND · Jun 29, 2026

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Clearmind Medicine Inc. (Nasdaq: CMND) has been granted a new U.S. patent, bolstering its global patent portfolio. The announcement was made following the approval by the United States Patent and Trademark Office.

The new patent is expected to provide Clearmind with enhanced protection for its innovative treatments in the biotechnology sector. The company now holds a stronger intellectual property position as it continues to develop its pipeline of pharmaceutical products.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time CMND sparks.

Download Sniper App →

Catch the next CMND-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →